Joint PSI/EFSPI Vaccine SIG Webinar: Statistical and Mechanistic Models for Correlates of Protection
This webinar will explore two different approaches to Correlates of Protection in vaccine development.
CHAIR: Graham Healey, Oncimmune Ltd
Toxicology SIG
Speaker: Helena Geys, Janssen Pharmaceutica and Philip Jarvis, AstraZeneca
An assessment of the statistical methods used to analyse toxicology studies
Co-authors: Jim Saul, Mike Aylott, Simon Bate and John Sherington;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 477-484, November/December 2011
Abstract | Paper+ | Slides
Biomarker SIG
Speaker: Martin Jenkins, AstraZeneca and Chris Harbron, AstraZeneca
A statistician's perspective on biomarkers in drug development
Co-authors: Aiden Flynn, Trevor Smart, Tony Sabin, Jayantha Ratnayake, Paul Delmar, Athula Herath, Philip Jarvis and James Matcham;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 494-507, November/December 2011
Abstract | Paper+ | Slides
CHAIR: Graham Healey, Oncimmune Ltd
Toxicology SIG
Speaker: Helena Geys, Janssen Pharmaceutica and Philip Jarvis, AstraZeneca
An assessment of the statistical methods used to analyse toxicology studies
Co-authors: Jim Saul, Mike Aylott, Simon Bate and John Sherington;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 477-484, November/December 2011
Abstract | Paper+ | Slides
Biomarker SIG
Speaker: Martin Jenkins, AstraZeneca and Chris Harbron, AstraZeneca
A statistician's perspective on biomarkers in drug development
Co-authors: Aiden Flynn, Trevor Smart, Tony Sabin, Jayantha Ratnayake, Paul Delmar, Athula Herath, Philip Jarvis and James Matcham;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 494-507, November/December 2011
Abstract | Paper+ | Slides
CHAIR: Graham Healey, Oncimmune Ltd
Toxicology SIG
Speaker: Helena Geys, Janssen Pharmaceutica and Philip Jarvis, AstraZeneca
An assessment of the statistical methods used to analyse toxicology studies
Co-authors: Jim Saul, Mike Aylott, Simon Bate and John Sherington;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 477-484, November/December 2011
Abstract | Paper+ | Slides
Biomarker SIG
Speaker: Martin Jenkins, AstraZeneca and Chris Harbron, AstraZeneca
A statistician's perspective on biomarkers in drug development
Co-authors: Aiden Flynn, Trevor Smart, Tony Sabin, Jayantha Ratnayake, Paul Delmar, Athula Herath, Philip Jarvis and James Matcham;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 494-507, November/December 2011
Abstract | Paper+ | Slides
CHAIR: Graham Healey, Oncimmune Ltd
Toxicology SIG
Speaker: Helena Geys, Janssen Pharmaceutica and Philip Jarvis, AstraZeneca
An assessment of the statistical methods used to analyse toxicology studies
Co-authors: Jim Saul, Mike Aylott, Simon Bate and John Sherington;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 477-484, November/December 2011
Abstract | Paper+ | Slides
Biomarker SIG
Speaker: Martin Jenkins, AstraZeneca and Chris Harbron, AstraZeneca
A statistician's perspective on biomarkers in drug development
Co-authors: Aiden Flynn, Trevor Smart, Tony Sabin, Jayantha Ratnayake, Paul Delmar, Athula Herath, Philip Jarvis and James Matcham;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 494-507, November/December 2011
Abstract | Paper+ | Slides
CHAIR: Graham Healey, Oncimmune Ltd
Toxicology SIG
Speaker: Helena Geys, Janssen Pharmaceutica and Philip Jarvis, AstraZeneca
An assessment of the statistical methods used to analyse toxicology studies
Co-authors: Jim Saul, Mike Aylott, Simon Bate and John Sherington;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 477-484, November/December 2011
Abstract | Paper+ | Slides
Biomarker SIG
Speaker: Martin Jenkins, AstraZeneca and Chris Harbron, AstraZeneca
A statistician's perspective on biomarkers in drug development
Co-authors: Aiden Flynn, Trevor Smart, Tony Sabin, Jayantha Ratnayake, Paul Delmar, Athula Herath, Philip Jarvis and James Matcham;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 494-507, November/December 2011
Abstract | Paper+ | Slides
CHAIR: Graham Healey, Oncimmune Ltd
Toxicology SIG
Speaker: Helena Geys, Janssen Pharmaceutica and Philip Jarvis, AstraZeneca
An assessment of the statistical methods used to analyse toxicology studies
Co-authors: Jim Saul, Mike Aylott, Simon Bate and John Sherington;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 477-484, November/December 2011
Abstract | Paper+ | Slides
Biomarker SIG
Speaker: Martin Jenkins, AstraZeneca and Chris Harbron, AstraZeneca
A statistician's perspective on biomarkers in drug development
Co-authors: Aiden Flynn, Trevor Smart, Tony Sabin, Jayantha Ratnayake, Paul Delmar, Athula Herath, Philip Jarvis and James Matcham;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 494-507, November/December 2011
Abstract | Paper+ | Slides